BPC-157 has demonstrated significant gastroprotective effects in preclinical studies: healing of gastric ulcers, protection against lesions induced by NSAIDs and ethanol, improvement of experimental colitis
Monitoring: Frequent initial follow-ups (surgeon's schedule, typically daily to weekly first month), objective healing markers (corneal clarity, retinal reattachment, vision recovery), reduce intensity as healing progresses
Morgan AS, Ciaccio PJ, Tew KD, Kauvar LM
Actual fat loss follows from weeks three or four onwards at the starter dose, accelerating as the dose increases
"Anti-obesity drug discovery: advances and challenges"
Vitamin B12 (Cyanocobalamin), Vitamin B (Thiamine hydrochloride), Vitamin B2 (Riboflavin), Calcium pantothenate, Sweetener: Sucralose